NCT04209205 · Interventional trial
Study to Demonstrate the Efficacy, Safety and Tolerability of Intravenous Secukinumab up to 52 Weeks in Subjects With Active Psoriatic Arthritis
Overall registry status Completed
Phase 3
Conditions Psoriatic Arthritis
Delaware Valley sites
- Novartis Investigative Site · Voorhees Township, NJ · Camden County
First posted
Registry updated
Added to the directory